Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa

Published:2009-01-28 Issue:3 Volume:23 Page:335-342
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Lawn Stephen D,Little Francesca,Bekker Linda-Gail,Kaplan Richard,Campbel Elizabeth,Orrell Catherine,Wood Robin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference24 articles.

1. Scaling up antiretroviral therapy in South Africa: the impact of speed on survival;Walensky;J Infect Dis,2008

2. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa;Lawn;AIDS,2008

3. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries;Braitstein;Lancet,2006

4. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design;Lawn;AIDS,2005

5. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes;Stringer;JAMA,2006

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of Cryptococcal Antigenemia and Lateral Flow Assay Accuracy in Severely Immunosuppressed AIDS Patients;Journal of Fungi;2024-07-16

2. Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART;PLOS ONE;2023-03-30

3. Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus;Current Opinion in Infectious Diseases;2023-02

4. Sieve Estimation of a Class of Partially Linear Transformation Models With Interval-Censored Competing Risks Data;Statistica Sinica;2023

5. Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection;New England Journal of Medicine;2022-05-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3